|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2000-10-5
|
|
pubmed:abstractText |
Critically ill patients often are anemic, which may impair oxygen delivery. Transfusion of red cells and supplementation with vitamins or iron are the usual therapeutic strategies, whereas only sporadic data are available on the use of epoetin alfa in these patients. We investigated endogenous erythropoietin (EPO) production and the response to epoetin alfa in anemic intensive care unit (ICU) patients.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0090-3493
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2773-8
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10966249-Adult,
pubmed-meshheading:10966249-Aged,
pubmed-meshheading:10966249-Aged, 80 and over,
pubmed-meshheading:10966249-Critical Illness,
pubmed-meshheading:10966249-Erythropoiesis,
pubmed-meshheading:10966249-Erythropoietin,
pubmed-meshheading:10966249-Female,
pubmed-meshheading:10966249-Humans,
pubmed-meshheading:10966249-Intensive Care Units,
pubmed-meshheading:10966249-Iron,
pubmed-meshheading:10966249-Male,
pubmed-meshheading:10966249-Middle Aged,
pubmed-meshheading:10966249-Prospective Studies,
pubmed-meshheading:10966249-Recombinant Proteins
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients.
|
|
pubmed:affiliation |
Department of Internal Medicine, Amersfoort, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
